AUBREY SMITH: Open Payments
NPI 1780278473 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 19 payments from 10 companies in 2025. Trend: 2023 $242 · 2024 $288 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $128 |
| Lilly USA, LLC | 1 | $109 |
| AstraZeneca Pharmaceuticals LP | 3 | $107 |
| ABIOMED | 1 | $104 |
| Amgen Inc. | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Novo Nordisk Inc | 2 | $52 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| PFIZER INC. | 1 | $15 |
Products named: WATCHMAN FLX, MOUNJARO, LOKELMA, LEQVIO, Wegovy, FARXIGA, LifeVest, XIFAXAN.
Industry payments across NC — which companies pay providers there.
